Nipple Correction Surgery in India and UAE | Complete Patient Guide

• IDEAL SURGICAL CANDIDATES:

• Women or men with Grade I, II, or III inverted nipples causing cosmetic concern, recurrent infections, or breastfeeding difficulty

• Patients with nipple hypertrophy (nipple projection > 1 cm or diameter disproportionate to the areola) seeking reduction

• Individuals with areolar asymmetry or enlargement (areola diameter > 5–6 cm) following pregnancy, weight fluctuation, or prior breast surgery

• Breast cancer survivors requiring nipple-areola complex (NAC) reconstruction following mastectomy, with stable disease and completed adjuvant therapy

• Adults aged 18+ with realistic expectations and stable body weight (BMI ideally < 30 for optimal wound healing)

• Patients who have completed childbearing or who explicitly understand and accept the potential impact on future lactation capacity

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Bilateral digital mammography or breast ultrasound (for patients aged > 35 or with any suspicious findings) to exclude underlying pathology before elective nipple surgery

• MRI breast: indicated for post-mastectomy reconstruction candidates or when dense breast tissue limits mammographic sensitivity

• Full blood count (FBC), coagulation profile (PT/aPTT/INR), fasting glucose, and HbA1c (diabetes screening for wound-healing risk stratification)

• Hormonal assay (prolactin, TSH) if galactorrhoea or endocrine cause of nipple changes is suspected

• Pre-anaesthetic ECG and chest X-ray for patients over 40 or those with cardiovascular comorbidities

• High-resolution clinical photography (standardised — frontal, oblique, lateral) for surgical planning and medico-legal documentation

• CONTRAINDICATIONS & CAUTIONS:

• Active breast infection or periductal mastitis (surgery must be deferred until infection is fully resolved)

• Undiagnosed breast mass or suspicious mammographic/MRI finding (malignancy must be excluded before elective surgery)

• Active smokers (nicotine causes microvascular vasoconstriction significantly increasing necrosis risk; cessation ≥ 4–6 weeks pre-operatively is mandatory)

• Uncontrolled diabetes mellitus (HbA1c > 8% associated with impaired wound healing and infection risk)

• Bleeding disorders or mandatory anticoagulation therapy that cannot be safely bridged

• Strong desire for future breastfeeding in Grade III inversion cases (ductal division is inherent; patient must be counselled that lactation will be permanently compromised)

• Active autoimmune connective tissue disease (e.g., scleroderma) — relative contraindication due to poor tissue healing

• Pregnancy or lactation

GRADE-STRATIFIED SURGICAL APPROACHES FOR INVERTED NIPPLE CORRECTION:

1. SUTURE-BASED EVERSION (Grade I — Minimally Invasive):

For mild inversion with intact or minimally tethered lactiferous ducts, a purse-string or internal sling suture technique (e.g., the Broadbent-Woolf or modified Teimourian technique) is performed through a small periareolar puncture under local anaesthesia. A permanent or long-lasting absorbable monofilament suture (e.g., 3-0 PDS or Gore-Tex CV-4) creates a subcutaneous hammock to maintain nipple projection. Ductal integrity is fully preserved. This is an office or day-care procedure with near-zero downtime.

2. DUCTAL RELEASE WITH FLAP SUPPORT (Grade II & III — Standard Surgical Correction):

For moderate-to-severe inversion, the defining pathology is fibrotic shortening of the lactiferous ducts and fibrous bands. The procedure involves a periareolar or radial incision, sharp division of the tethering fibrous stroma and, when necessary, partial or complete division of the lactiferous ducts (patients must be counselled that breastfeeding capacity will be reduced or eliminated). Sustained eversion is maintained by one of several validated internal support strategies: the dermal-fat flap (recruitment of local periareolar dermis folded beneath the nipple base), the double-opposing-tab flap, or the Huang technique using de-epithelialised areolar tissue. Closure is performed with deep 4-0 Vicryl and superficial 5-0 or 6-0 Prolene or Monocryl sutures. A nipple stent or bolster dressing (e.g., a silicone nipple shield or foam donut) is applied for 4–6 weeks post-operatively to resist retraction during healing.

3. NIPPLE REDUCTION (Hypertrophy Correction):

Excision of excess nipple tissue is achieved via wedge resection, cylindrical core excision, or the amputation-with-centrally-pedicled flap technique, depending on the degree of projection excess and diameter. The goal is a nipple projection of 5–8 mm and a diameter of 10–13 mm, harmonious with the areola. Sensation is generally preserved because dorsal sensory nerve branches are identified and protected. Performed under local anaesthesia with or without sedation; scar is concealed within the nipple-areola junction.

4. AREOLA REDUCTION / RESHAPING (Periareolar Mastopexy Variant):

Benelli (round-block) technique: concentric de-epithelialisation of the excess areolar skin using a custom-designed cookie-cutter template, with closure using a permanent purse-string suture (Mersilene 2-0) placed intradermally to prevent areolar re-expansion. May be combined with minor mastopexy if there is coincident ptosis. Scar is at the pigment-skin junction and becomes inconspicuous.

5. NIPPLE-AREOLA COMPLEX (NAC) RECONSTRUCTION (Post-Mastectomy):

This multi-stage process represents the most complex tier. Stage 1 involves local flap nipple reconstruction using the C-V flap, star flap, or skate flap, performed 3–6 months after implant-based or autologous breast reconstruction once the breast mound has fully settled. Stage 2 (performed 6–8 weeks later) involves 3D areola micropigmentation (medical tattooing) by a specialist paramedical tattoo artist to recreate areolar colour, texture, and the Montgomery gland pattern. Alternatively, full-thickness skin grafting from the inner thigh or contralateral areola sharing may be used. Fat grafting (Coleman technique, centrifuged autologous fat) is sometimes added simultaneously to improve projection longevity.

6. TECHNOLOGY & ADJUNCTS:

• Loupe magnification (2.5x–4.5x) for precise tissue handling

• Bipolar electrocautery for haemostasis with minimal thermal spread

• Ultrasound-assisted liposuction (UAL/VASER) if concurrent areolar fat reduction is required

• Platelet-Rich Plasma (PRP) injection at wound margins to accelerate healing — offered at select centres

• 3D imaging simulation (Vectra 3D system) for pre-operative outcome visualisation at premium facilities in Dubai

PHASE 1 — PRE-OPERATIVE PREPARATION (Weeks 1–3 Before Travel):

• GAF Healthcare assigns a dedicated Patient Coordinator who collects medical records, photographs, and diagnostic reports and transmits them to the chosen surgical team for a virtual consultation.

• Surgeon reviews imaging and issues a personalised treatment plan with technique recommendation, anaesthesia type, and written consent documentation.

• Patient receives a pre-operative checklist: smoking cessation (minimum 4–6 weeks), discontinuation of aspirin/NSAIDs/blood thinners (10–14 days prior), vitamin E supplements stopped (2 weeks prior), and fasting protocol for the procedure day.

• GAF arranges e-Medical Visa (India) or UAE entry visa, airport pick-up, and hospital registration remotely.

PHASE 2 — ARRIVAL & PRE-OP ASSESSMENT (Day 1–2 in Destination):

• Airport transfer to accredited hospital or partner hotel.

• Admission/outpatient registration; pre-anaesthetic review by anaesthesiologist.

• On-site blood tests, ECG, and breast ultrasound (if not already performed) are completed within 24 hours.

• Pre-operative consultation with operating surgeon: markings reviewed, consent signed, questions addressed.

• Nil by mouth from midnight before procedure day.

PHASE 3 — THE PROCEDURE (Day 2 or 3):

• Most nipple correction procedures are performed under local anaesthesia with or without intravenous (IV) conscious sedation (propofol + midazolam titrated); general anaesthesia is reserved for simultaneous breast procedures or patient preference.

• Operative time: 30–60 minutes for isolated inverted nipple correction or reduction; 90–120 minutes for bilateral correction with areola reshaping; 2–3 hours for NAC reconstruction with flap work.

• Patients typically recover in the day-surgery unit for 2–4 hours before discharge (Grade I/II cases) or are admitted overnight for observation (Grade III bilateral or NAC reconstruction).

PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY (Days 3–7):

• Discharge with compression/support garment (soft bralette — underwire bras avoided for 6 weeks), written wound care instructions, and a 5-day course of prophylactic oral antibiotics (typically cefalexin or amoxicillin-clavulanate) plus analgesics (paracetamol and ibuprofen; opioids rarely required).

• Nipple stent or silicone bolster applied and worn 23 hours/day for 4–6 weeks to maintain projection.

• First post-operative review with surgeon at Day 5–7: wound inspection, suture check (absorbable sutures dissolve; non-absorbable removed at Day 7–10).

• Mild bruising and swelling expected; ice packs (indirect) applied for the first 48 hours.

• Showering permitted after 48 hours; bathing/swimming avoided for 3–4 weeks.

PHASE 5 — INTERMEDIATE RECOVERY & FIT-TO-FLY ASSESSMENT (Week 1–3):

• For short-haul flights (< 3 hours): patients are generally assessed as fit to fly at Day 7–10 following a clean wound check.

• For long-haul international flights (> 6 hours): the surgical team typically recommends a minimum of 2–3 weeks in-country to ensure wound integrity, absence of haematoma or infection, and suture removal before the physiological stress of pressurised cabin travel.

• Light daily activity permitted from Week 1; desk/computer work from Day 3–5.

• Avoid strenuous upper-body exercise, heavy lifting (> 5 kg), and contact sports for 4–6 weeks.

• Complete resolution of swelling: 6–12 weeks; final aesthetic result assessed at 3–6 months.

PHASE 6 — LONG-TERM FOLLOW-UP (Remote):

• GAF Healthcare facilitates teleconsultation follow-up appointments at 1 month, 3 months, and 6 months post-operatively via video call with the operating surgeon.

• Silicone scar gel (e.g., Kelo-cote or ScarAway) commenced at Week 3–4 and continued for 3–6 months to optimise scar maturation.

• Patients are provided with a comprehensive medical summary and operative report to share with their home-country physician.